| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 耳鼻喉科用药(元) | 128,240,371.36 | 267,519,458.48 | 151,303,088.04 | 264,895,292.84 | 152,538,671.15 |
| 精神神经系统用药(元) | 76,187,478.17 | 150,730,456.78 | 81,175,163.10 | 145,239,968.44 | 74,307,758.63 |
| 零售(元) | 825,251.60 | 726,328.26 | 418,575.45 | 1,873,154.86 | 1,040,119.52 |
| 商业流通(元) | 71,163,670.91 | 139,709,112.85 | 66,356,041.51 | 111,256,880.50 | 66,776,290.99 |
| 消化系统用药(元) | 101,461,686.71 | 190,972,987.81 | 102,361,536.12 | 178,524,736.35 | 86,267,239.70 |
| 激素及调节内分泌功能药物(元) | - | 5,484,565.62 | - | 8,324,221.56 | - |
| 其他领域用药(元) | 29,307,828.64 | 60,070,749.25 | 34,282,745.99 | 54,022,491.11 | 31,687,046.72 |
| 营业成本(元) | |||||
| 耳鼻喉科用药(元) | 23,630,232.52 | 55,283,989.47 | 30,318,435.80 | 58,247,798.58 | 30,858,950.54 |
| 精神神经系统用药(元) | 20,233,446.53 | 45,234,265.14 | 24,710,577.61 | 56,885,136.72 | 27,919,733.63 |
| 零售(元) | 359,407.58 | - | 372,668.02 | - | 764,553.91 |
| 商业流通(元) | 61,484,469.95 | 130,692,912.70 | 62,417,389.21 | 103,051,375.38 | 61,913,287.05 |
| 消化系统用药(元) | 48,739,891.63 | 93,218,125.53 | 50,612,843.04 | 83,300,152.81 | 40,091,697.09 |
| 激素及调节内分泌功能药物(元) | - | - | - | - | - |
| 其他领域用药(元) | 10,683,137.13 | - | 11,702,380.11 | - | 12,197,799.33 |
| 毛利(元) | |||||
| 耳鼻喉科用药(元) | 104,610,138.84 | 212,235,469.01 | 120,984,652.24 | 206,647,494.26 | 121,679,720.61 |
| 精神神经系统用药(元) | 55,954,031.64 | 105,496,191.64 | 56,464,585.49 | 88,354,831.72 | 46,388,025.00 |
| 零售(元) | 465,844.02 | - | 45,907.43 | - | 275,565.61 |
| 商业流通(元) | 9,679,200.96 | 9,016,200.15 | 3,938,652.30 | 8,205,505.12 | 4,863,003.94 |
| 消化系统用药(元) | 52,721,795.08 | 97,754,862.28 | 51,748,693.08 | 95,224,583.54 | 46,175,542.61 |
| 激素及调节内分泌功能药物(元) | - | - | - | - | - |
| 其他领域用药(元) | 18,624,691.51 | - | 22,580,365.88 | - | 19,489,247.39 |
| 毛利率(%) | |||||
| 耳鼻喉科用药(%) | 81.57 | 79.33 | 79.96 | 78.01 | 79.77 |
| 精神神经系统用药(%) | 73.44 | 69.99 | 69.56 | 60.83 | 62.43 |
| 零售(%) | 56.45 | - | 10.97 | - | 26.49 |
| 商业流通(%) | 13.60 | 6.45 | 5.94 | 7.38 | 7.28 |
| 消化系统用药(%) | 51.96 | 51.19 | 50.55 | 53.34 | 53.53 |
| 激素及调节内分泌功能药物(%) | - | - | - | - | - |
| 其他领域用药(%) | 63.55 | - | 65.87 | - | 61.51 |
| 收入构成(%) | |||||
| 耳鼻喉科用药(%) | 31.49 | 32.82 | 34.71 | 34.67 | 36.97 |
| 精神神经系统用药(%) | 18.71 | 18.49 | 18.62 | 19.01 | 18.01 |
| 零售(%) | 0.20 | 0.09 | 0.10 | 0.25 | 0.25 |
| 商业流通(%) | 17.48 | 17.14 | 15.22 | 14.56 | 16.18 |
| 消化系统用药(%) | 24.92 | 23.43 | 23.48 | 23.36 | 20.91 |
| 激素及调节内分泌功能药物(%) | - | 0.67 | - | 1.09 | - |
| 其他领域用药(%) | 7.20 | 7.37 | 7.86 | 7.07 | 7.68 |
| 毛利构成(%) | |||||
| 耳鼻喉科用药(%) | 43.22 | 50.00 | 47.30 | 51.87 | 50.94 |
| 精神神经系统用药(%) | 23.12 | 24.85 | 22.08 | 22.18 | 19.42 |
| 零售(%) | 0.19 | 0.00 | 0.02 | 0.00 | 0.12 |
| 商业流通(%) | 4.00 | 2.12 | 1.54 | 2.06 | 2.04 |
| 消化系统用药(%) | 21.78 | 23.03 | 20.23 | 23.90 | 19.33 |
| 激素及调节内分泌功能药物(%) | - | 0.00 | - | 0.00 | - |
| 其他领域用药(%) | 7.69 | 0.00 | 8.83 | 0.00 | 8.16 |